Kybella® (deoxycholic acid) is the first and only FDA-approved injectable treatment to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells.
Submental fullness, also known as "Double Chin," is a common concern among facial aesthetic oriented patients. According to a 2015 survey conducted by the American Society for Dermatologic Surgery, nearly as many consumers are bothered by their double chin (67%) as by lines and wrinkles around the eyes (69%).
Submental fullness can impact both men and women. Possible causes include genetics, weight gain and aging. Sometimes, even with diet or exercise, the unwanted fullness beneath the chin may not go away, and can cause a person to appear older or heavier than they actually are.
The active ingredient in Kybella® is deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
When injected into the fat beneath the chin, Kybella® physically destroys fat cells, making them unable to accumulate or store fat.
Once destroyed, fat cleared from the treatment area is process through the body's natural metabolic mechanisms.
Kybella® is injected during a series of in-office visits. The injection process may take 15 to 20 minutes.
What is Kybella®?
Kybella® is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”
It is not known if Kybella® is safe and effective for use outside of the submental area or in children under the age of 18.
Who should not receive Kybella®?
You should not receive Kybella® if you have an infection in the treatment area.
Please see additional Important Safety Information in the following information packet by clicking below: